Zantac Recall and FDA Actions: What Patients Need to Know
pharmaceuticals
In the early 2020s, ranitidine (Zantac) was removed from U.S. shelves after regulators found unacceptable levels of NDMA, a probable human carcinogen. The FDA requested recalls...
Open article